{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:59:32Z","timestamp":1781643572923,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2024\/53\/B\/NZ5\/00343"],"award-info":[{"award-number":["UMO-2024\/53\/B\/NZ5\/00343"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Polish Ministry of Science and Education","award":["IA\/SP\/490536\/2021"],"award-info":[{"award-number":["IA\/SP\/490536\/2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Delayed cerebral ischemia (DCI) affects approximately 30% of aneurysmal subarachnoid hemorrhage (aSAH) survivors and is a leading cause of morbidity and mortality post-aSAH. Current risk assessment relies on radiographic severity scores that stratify populations based on hemorrhage characteristics but cannot predict DCI onset for individual patients. No plasma-based biomarkers for DCI prediction currently exist. We used liquid chromatography \u2013 mass spectrometry to perform plasma metabolomics in 60 aSAH patients (50% female, 30 DCI, 30 No-DCI) with longitudinal sampling until 7 days post-aSAH. Samples were retrospectively aligned to individual DCI onset times per patient, isolating 24\u201348\u00a0h and 48\u201372\u00a0h pre-event windows. Arginine emerged as the sole FDR-significant metabolite 24\u201348\u00a0h before DCI (q\u2009=\u20090.022, 39% depletion) and ranked #1 of 2,022 metabolites across three statistical methods (Student\u2019s t-test, Welch\u2019s t-test, Mann-Whitney U test,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u200910\u207b\u2075 to 10\u207b\u2074). Zero metabolites achieved FDR significance at 48\u201372\u00a0h, confirming temporal specificity. Independent logistic regression validated predictive performance (odds ratio 0.22,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001, AUC 0.808, 95% CI: 0.647\u20130.945), outperforming modified Fisher radiographic score (AUC 0.718, 95% CI: 0.593\u20130.830). The combination model of arginine and modified Fisher score performed best with AUC 0.856 (95% CI: 0.733\u20130.955), with arginine as the dominant factor. Mechanistic investigation revealed FDR-significant depletion of arginine\/ornithine (q\u2009=\u20090.011) and glutamine\/glutamate ratios (q\u2009=\u20090.011), consistent with increased arginase activity competing with nitric oxide synthesis. Plasma arginine represents a candidate single-molecule biomarker for DCI with a clinically actionable pre-event detection window, pending prospective validation. Temporal alignment to individual DCI onsets enabled detection of pre-event metabolic changes 24\u201348\u00a0h before symptom onset.\n                  <\/jats:p>","DOI":"10.1007\/s12975-026-01421-0","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:02:29Z","timestamp":1774404149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotype-Aligned Metabolomics Identifies Plasma Arginine as a Candidate Predictor of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6645-6893","authenticated-orcid":false,"given":"Krzysztof","family":"Urbanowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-0305","authenticated-orcid":false,"given":"Karol","family":"Wi\u015bniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3423-3745","authenticated-orcid":false,"given":"Miko\u0142aj","family":"Opie\u0142ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-3928","authenticated-orcid":false,"given":"Micha\u0142","family":"Bie\u0144kowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4596-4837","authenticated-orcid":false,"given":"Marta","family":"Pop\u0119da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0056-1761","authenticated-orcid":false,"given":"Oliwier","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1891-3791","authenticated-orcid":false,"given":"Ernest J.","family":"Bobeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8115-6030","authenticated-orcid":false,"given":"Karol","family":"Zaczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4051-0887","authenticated-orcid":false,"given":"Bartosz","family":"Szmyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9971-9677","authenticated-orcid":false,"given":"Dariusz J.","family":"Jask\u00f3lski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-9414","authenticated-orcid":false,"given":"Ryszard T.","family":"Smole\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"1421_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46015-2","author":"S Thilak","year":"2024","unstructured":"Thilak S, Brown P, Whitehouse T, Gautam N, Lawrence E, Ahmed Z, et al. Diagnosis and management of subarachnoid haemorrhage. Nat Commun Nat Res. 2024. https:\/\/doi.org\/10.1038\/s41467-024-46015-2.","journal-title":"Nat Commun Nat Res"},{"key":"1421_CR2","doi-asserted-by":"publisher","unstructured":"Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit. Care. BioMed Central Ltd.; 2016. https:\/\/doi.org\/10.1186\/s13054-016-1447-6.","DOI":"10.1186\/s13054-016-1447-6"},{"key":"1421_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/jcbfm.2013.208","volume":"34","author":"CHP Cremers","year":"2014","unstructured":"Cremers CHP, Van Der Schaaf IC, Wensink E, Greving JP, Rinkel GJE, Velthuis BK, et al. CT perfusion and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. J Cereb Blood Flow Metab. 2014;34:200\u20137. https:\/\/doi.org\/10.1038\/jcbfm.2013.208.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1421_CR4","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.acra.2012.04.010","volume":"19","author":"PC Sanelli","year":"2012","unstructured":"Sanelli PC, Anumula N, Gold R, Elias E, Johnson C, Comunale J, et al. Outcomes-based assessment of a new reference standard for delayed cerebral ischemia related to vasospasm in aneurysmal subarachnoid hemorrhage. Acad Radiol. 2012;19:1066\u201374. https:\/\/doi.org\/10.1016\/j.acra.2012.04.010.","journal-title":"Acad Radiol"},{"key":"1421_CR5","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/STROKEAHA.115.008728","volume":"46","author":"AL De Oliveira Manoel","year":"2015","unstructured":"De Oliveira Manoel AL, Jaja BN, Germans MR, Yan H, Qian W, Kouzmina E, et al. The VASOGRADE: A simple grading scale for prediction of delayed cerebral ischemia after subarachnoid hemorrhage. Stroke Lippincott Williams Wilkins. 2015;46:1826\u201331. https:\/\/doi.org\/10.1161\/STROKEAHA.115.008728.","journal-title":"Stroke Lippincott Williams Wilkins"},{"issue":"1","key":"1421_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1227\/01.neu.0000243277.86222.6c","volume":"59","author":"JA Frontera","year":"2006","unstructured":"Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurg Wolters Kluwer. 2006;59(1):21\u20137. https:\/\/doi.org\/10.1227\/01.neu.0000243277.86222.6c.","journal-title":"Neurosurg Wolters Kluwer"},{"key":"1421_CR7","doi-asserted-by":"publisher","unstructured":"Mittal AM, Nowicki KW, Mantena R, Cao C, Rochlin EK, Dembinski R, et al. Advances in biomarkers for vasospasm \u2013 Towards a future blood-based diagnostic test. World Neurosurg. X. Elsevier Inc.; 2024. https:\/\/doi.org\/10.1016\/j.wnsx.2024.100343.","DOI":"10.1016\/j.wnsx.2024.100343"},{"key":"1421_CR8","doi-asserted-by":"publisher","unstructured":"Tjerkstra MA, Labib H, Coert BA, Spijker R, Coutinho JM, Peter Vandertop W, et al. Laboratory biomarkers of delayed cerebral ischemia following subarachnoid hemorrhage: A systematic review. J Circ Biomark AboutScience Srl. 2023;17\u201325. https:\/\/doi.org\/10.33393\/jcb.2023.2502.","DOI":"10.33393\/jcb.2023.2502"},{"key":"1421_CR9","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1021\/acschemneuro.8b00581","volume":"10","author":"YC Li","year":"2019","unstructured":"Li YC, Wang R, Xu MM, Jing XR, Ji-Ye A, Sun R, Bin, et al. Aneurysmal subarachnoid hemorrhage onset alters pyruvate metabolism in Poor-Grade patients and clinical outcome depends on more: A cerebrospinal fluid metabolomic study. ACS Chem Neurosci Am Chem Soc. 2019;10:1660\u20137. https:\/\/doi.org\/10.1021\/acschemneuro.8b00581.","journal-title":"ACS Chem Neurosci Am Chem Soc"},{"key":"1421_CR10","doi-asserted-by":"publisher","unstructured":"Sok\u00f3\u0142 B, Urbaniak B, W\u0105sik N, Plewa S, Klupczy\u0144ska A, Jankowski R, et al. Amino acids in cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage: an observational study. Front Neurol Front Media S A. 2017;8. https:\/\/doi.org\/10.3389\/fneur.2017.00438.","DOI":"10.3389\/fneur.2017.00438"},{"key":"1421_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/02688697.2018.1519107","volume":"32","author":"AY Lu","year":"2018","unstructured":"Lu AY, Damisah EC, Winkler EA, Grant RA, Eid T, Bulsara KR. Cerebrospinal fluid untargeted metabolomic profiling of aneurysmal subarachnoid hemorrhage: an exploratory study. Br J Neurosurg Taylor Francis Ltd. 2018;32:637\u201341. https:\/\/doi.org\/10.1080\/02688697.2018.1519107.","journal-title":"Br J Neurosurg Taylor Francis Ltd"},{"key":"1421_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/neuros\/nyaa557","volume-title":"Machine Learning-Driven metabolomic evaluation of cerebrospinal fluid: insights into poor outcomes after aneurysmal subarachnoid hemorrhage","author":"M Koch","year":"2021","unstructured":"Koch M, Acharjee A, Ament Z, Schleicher R, Bevers M, Stapleton C, et al. Machine Learning-Driven metabolomic evaluation of cerebrospinal fluid: insights into poor outcomes after aneurysmal subarachnoid hemorrhage. Volume 88. Neurosurgery: Oxford University Press; 2021. pp. 1003\u201311. https:\/\/doi.org\/10.1093\/neuros\/nyaa557."},{"key":"1421_CR13","doi-asserted-by":"publisher","unstructured":"Ho WM, G\u00f6rke AS, Glodny B, Oberacher H, Helbok R, Thom\u00e9 C, et al. Time course of metabolomic alterations in cerebrospinal fluid after aneurysmal subarachnoid Hemorrhage. Front neurol. Front Media S A. 2020;11. https:\/\/doi.org\/10.3389\/fneur.2020.00589.","DOI":"10.3389\/fneur.2020.00589"},{"key":"1421_CR14","doi-asserted-by":"publisher","unstructured":"Pacheco G, Gomes JA, Cho K, Morris DL, Segal MI, Adkins-Travis KR, et al. Iron accumulation and metabolic alterations in aneurysmal subarachnoid Hemorrhage. Stroke: vascular and interventional neurology. Ovid Technol (Wolters Kluwer Health). 2024;4. https:\/\/doi.org\/10.1161\/svin.123.000848.","DOI":"10.1161\/svin.123.000848"},{"key":"1421_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12975-021-00944-y","volume":"13","author":"J Zimmermann","year":"2022","unstructured":"Zimmermann J, Weller J, Grub S, Kebir S, Lehmann F, Vatter H, et al. Arginase-1 released into CSF after aneurysmal subarachnoid hemorrhage decreases Arginine\/Ornithine ratio: a novel prognostic biomarker. Transl Stroke Res Springer. 2022;13:382\u201390. https:\/\/doi.org\/10.1007\/s12975-021-00944-y.","journal-title":"Transl Stroke Res Springer"},{"key":"1421_CR16","doi-asserted-by":"publisher","unstructured":"Weller J, Lampmann T, Asoglu H, Schneider M, Ehrentraut SF, Lehmann F, et al. Additive prognostic impact of the cerebrospinal fluid arginine\/ornithine ratio to established clinical scores in aneurysmal subarachnoid hemorrhage. Front Neurol Front Media S A. 2023;14. https:\/\/doi.org\/10.3389\/fneur.2023.1156505.","DOI":"10.3389\/fneur.2023.1156505"},{"key":"1421_CR17","doi-asserted-by":"publisher","unstructured":"Appel D, Seeberger M, Schwedhelm E, Czorlich P, Goetz AE, B\u00f6ger RH, et al. Asymmetric and symmetric dimethylarginines are markers of delayed cerebral ischemia and neurological outcome in patients with subarachnoid hemorrhage. Neurocrit care. Volume 29. Humana Press Inc.; 2018. pp. 84\u201393. https:\/\/doi.org\/10.1007\/s12028-018-0520-1.","DOI":"10.1007\/s12028-018-0520-1"},{"key":"1421_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3171\/JNS-07\/11\/0945","volume":"107","author":"CS Jung","year":"2007","unstructured":"Jung CS, Oldfield EH, Harvey-White J, Espey MG, Zimmermann M, Seifert V, et al. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2007;107:945\u201350. https:\/\/doi.org\/10.3171\/JNS-07\/11\/0945.","journal-title":"J Neurosurg"},{"key":"1421_CR19","doi-asserted-by":"publisher","unstructured":"Chikh K, Tonon D, Triglia T, Lagier D, Buisson A, Alessi M-C et al. Early metabolic disruption and predictive biomarkers of delayed-cerebral ischemia in aneurysmal subarachnoid haemorrhage [Internet]. 2023. https:\/\/doi.org\/10.1101\/2023.04.26.23289184","DOI":"10.1101\/2023.04.26.23289184"},{"key":"1421_CR20","doi-asserted-by":"publisher","unstructured":"Snider S, Albano L, Gagliardi F, Comai S, Roncelli F, De Domenico P, et al. Substantially elevated serum glutamate and CSF GOT-1 levels associated with cerebral ischemia and poor neurological outcomes in subarachnoid hemorrhage patients. Sci Rep Nat Res. 2023;13. https:\/\/doi.org\/10.1038\/s41598-023-32302-3.","DOI":"10.1038\/s41598-023-32302-3"},{"key":"1421_CR21","doi-asserted-by":"publisher","unstructured":"Yang BSK, Savarraj JPJ, Chen H, Hinds SN, Torres GL, Ryan AS et al. Systemic Metabolic Alterations after Aneurysmal Subarachnoid Hemorrhage: A Plasma Metabolomics Approach [Internet]. 2025. https:\/\/doi.org\/10.1101\/2025.01.06.25320083","DOI":"10.1101\/2025.01.06.25320083"},{"key":"1421_CR22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3171\/2024.9.JNS241068","volume":"142","author":"K Wi\u015bniewski","year":"2025","unstructured":"Wi\u015bniewski K, Zaczkowski K, Pop\u0119da M, Urbanowicz K, Szmyd B, Price B, et al. Improved accuracy of delayed cerebral ischemia diagnosis with plasma nitric oxide synthase 3, nicotinamide adenine dinucleotide phosphate, and 8-iso-prostaglandin F2\u03b1. J Neurosurg Am Association Neurol Surg. 2025;142:1437\u201348. https:\/\/doi.org\/10.3171\/2024.9.JNS241068.","journal-title":"J Neurosurg Am Association Neurol Surg"},{"key":"1421_CR23","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDI Vergouwen","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391\u20135. https:\/\/doi.org\/10.1161\/STROKEAHA.110.589275.","journal-title":"Stroke"},{"key":"1421_CR24","doi-asserted-by":"publisher","unstructured":"Chojnowski K, Opie\u0142ka M, Urbanowicz K, Zawadzka M, Wangin K, Smole\u0144ski RT, et al. Untargeted metabolomics reveals key metabolic alterations in pediatric epilepsy with insights into Tryptophan metabolism and the gut\u2013brain axis. Sci Rep Nat Res. 2025;15. https:\/\/doi.org\/10.1038\/s41598-025-99805-z.","DOI":"10.1038\/s41598-025-99805-z"},{"key":"1421_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.8b05592","author":"S Fan","year":"2019","unstructured":"Fan S, Kind T, Cajka T, Hazen SL, Tang WHW, Kaddurah-Daouk R, et al. Anal Chem Am Chem Soc. 2019;91:3590\u20136. https:\/\/doi.org\/10.1021\/acs.analchem.8b05592. Systematic Error Removal Using Random Forest for Normalizing Large-Scale Untargeted Lipidomics Data."},{"key":"1421_CR26","doi-asserted-by":"publisher","unstructured":"Wishart DS, Guo AC, Oler E, Wang F, Anjum A, Peters H, et al. HMDB 5.0: the human metabolome database for 2022. Nucleic acids res. Volume 50. Oxford University Press; 2022. pp. D622\u201331. https:\/\/doi.org\/10.1093\/nar\/gkab1062.","DOI":"10.1093\/nar\/gkab1062"},{"key":"1421_CR27","doi-asserted-by":"publisher","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. Oxford University Press; 2023;51:D587\u201392. https:\/\/doi.org\/10.1093\/nar\/gkac963","DOI":"10.1093\/nar\/gkac963"},{"key":"1421_CR28","doi-asserted-by":"publisher","unstructured":"Schymanski EL, Jeon J, Gulde R, Fenner K, Ruff M, Singer HP, et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol. 2014;2097\u20138. https:\/\/doi.org\/10.1021\/es5002105.","DOI":"10.1021\/es5002105"},{"key":"1421_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr304","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur. Heart J. 2012. https:\/\/doi.org\/10.1093\/eurheartj\/ehr304.","journal-title":"Heart J"},{"key":"1421_CR30","doi-asserted-by":"publisher","unstructured":"F\u00f6rstermann U, M\u00fcnzel T. Endothelial nitric oxide synthase in vascular disease: from Marvel to menace. Circulation. 2006;1708\u201314. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.602532.","DOI":"10.1161\/CIRCULATIONAHA.105.602532"},{"key":"1421_CR31","doi-asserted-by":"publisher","unstructured":"Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294(1):81\u201390.. https:\/\/doi.org\/10.1001\/jama.294.1.81","DOI":"10.1001\/jama.294.1.81"},{"key":"1421_CR32","doi-asserted-by":"publisher","unstructured":"Morris CR, Kuypers FA, Kato GJ, Lavrisha L, Larkin S, Singer T, et al. Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y acad sci. New York Academy of Sciences; 2005. pp. 481\u20135. https:\/\/doi.org\/10.1196\/annals.1345.058.","DOI":"10.1196\/annals.1345.058"},{"key":"1421_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/545467","author":"P Stehle","year":"2015","unstructured":"Stehle P, Kuhn KS. Glutamine: an obligatory parenteral nutrition substrate in critical care therapy. Biomed Res Int Hindawi Publishing Corporation. 2015. https:\/\/doi.org\/10.1155\/2015\/545467.","journal-title":"Biomed Res Int Hindawi Publishing Corporation"},{"key":"1421_CR34","doi-asserted-by":"publisher","unstructured":"Cruzat V, Rogero MM, Keane KN, Curi R, Newsholme P, Glutamine. Metabolism and immune function, supplementation and clinical translation. Nutrients. MDPI AG; 2018. https:\/\/doi.org\/10.3390\/nu10111564.","DOI":"10.3390\/nu10111564"},{"key":"1421_CR35","doi-asserted-by":"publisher","unstructured":"Davis JS, Anstey NM. Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis. Crit. Care med. Lippincott Williams and Wilkins; 2011. pp. 380\u20135. https:\/\/doi.org\/10.1097\/CCM.0b013e3181ffd9f7.","DOI":"10.1097\/CCM.0b013e3181ffd9f7"},{"key":"1421_CR36","doi-asserted-by":"publisher","unstructured":"Kao C, Hsu J, Bandi V, Jahoor F. Alterations in glutamine metabolism and its conversion to citrulline in sepsis. Am J Physiol Endocrinol Metab. 2013;304. https:\/\/doi.org\/10.1152\/ajpendo.00628.2012.","DOI":"10.1152\/ajpendo.00628.2012"},{"key":"1421_CR37","doi-asserted-by":"publisher","unstructured":"van Waardenburg DA, de Betue CT, Luiking YC, Engel M, Deutz NE. Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. Am J Clin Nutr. 2007;86(5):1438\u201344. https:\/\/doi.org\/10.1093\/ajcn\/86.5.1438","DOI":"10.1093\/ajcn\/86.5.1438"},{"key":"1421_CR38","doi-asserted-by":"publisher","unstructured":"Marini JC. Interrelationships between glutamine and citrulline metabolism. Curr. Opin. Clin. Nutr. Metab. Care. Lippincott Williams and Wilkins; 2016. pp. 62\u20136. https:\/\/doi.org\/10.1097\/MCO.0000000000000233.","DOI":"10.1097\/MCO.0000000000000233"},{"key":"1421_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamaneurol.2023.1792","volume":"80","author":"S Wolf","year":"2023","unstructured":"Wolf S, Mielke D, Barner C, Malinova V, Kerz T, Wostrack M, et al. Effectiveness of lumbar cerebrospinal fluid drain among patients with aneurysmal subarachnoid hemorrhage: A randomized clinical trial. JAMA Neurol [Internet]. 2023;80:833\u201342. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1792.","journal-title":"JAMA Neurol [Internet]"},{"key":"1421_CR40","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1007\/s12035-019-1601-7","volume":"56","author":"S Tanioka","year":"2019","unstructured":"Tanioka S, Ishida F, Nakano F, Kawakita F, Kanamaru H, Nakatsuka Y, et al. Machine learning analysis of matricellular proteins and clinical variables for early prediction of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Mol Neurobiol Humana Press Inc. 2019;56:7128\u201335. https:\/\/doi.org\/10.1007\/s12035-019-1601-7.","journal-title":"Mol Neurobiol Humana Press Inc"},{"key":"1421_CR41","doi-asserted-by":"publisher","unstructured":"Schenck H, van Craenenbroeck C, van Kuijk S, Gommer E, Veldeman M, Temel Y, et al. Systematic review and meta-analysis of transcranial doppler biomarkers for the prediction of delayed cerebral ischemia following subarachnoid hemorrhage. Journal of cerebral blood flow and metabolism. SAGE Publications Ltd; 2025. pp. 1031\u201347. https:\/\/doi.org\/10.1177\/0271678X251313746.","DOI":"10.1177\/0271678X251313746"},{"key":"1421_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clinph.2022.08.023","volume":"143","author":"WL Zheng","year":"2022","unstructured":"Zheng WL, Kim JA, Elmer J, Zafar SF, Ghanta M, Moura Junior V, et al. Automated EEG-based prediction of delayed cerebral ischemia after subarachnoid hemorrhage. Clin Neurophysiol Elsevier Irel Ltd. 2022;143:97\u2013106. https:\/\/doi.org\/10.1016\/j.clinph.2022.08.023.","journal-title":"Clin Neurophysiol Elsevier Irel Ltd"},{"key":"1421_CR43","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.clnu.2019.08.013","volume":"39","author":"YC Luiking","year":"2020","unstructured":"Luiking YC, Poeze M, Deutz NE. A randomized-controlled trial of arginine infusion in severe sepsis on microcirculation and metabolism. Clin Nutr Churchill Livingstone. 2020;39:1764\u201373. https:\/\/doi.org\/10.1016\/j.clnu.2019.08.013.","journal-title":"Clin Nutr Churchill Livingstone"},{"key":"1421_CR44","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00134-003-1711-5","volume":"29","author":"G Bertolini","year":"2003","unstructured":"Bertolini G, Iapichino G, Radrizzani D, Facchini R, Simini B, Bruzzone P, et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med Springer Verlag. 2003;29:834\u201340. https:\/\/doi.org\/10.1007\/s00134-003-1711-5.","journal-title":"Intensive Care Med Springer Verlag"},{"key":"1421_CR45","doi-asserted-by":"publisher","unstructured":"Li Z, Wang L, Ren Y, Huang Y, Liu W, Lv Z, et al. Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases. Cell death discov. Springer Nature; 2022. https:\/\/doi.org\/10.1038\/s41420-022-01200-4.","DOI":"10.1038\/s41420-022-01200-4"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-026-01421-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:48:16Z","timestamp":1781642896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-026-01421-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1007\/s12975-026-01421-0","relation":{"references":[{"id-type":"doi","id":"10.1021\/acs.analchem.8b05592","asserted-by":"subject"}]},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and Good Clinical Practice and was approved by the Bioethics Committee at the Medical University of Lodz (approval number RNN\/34\/25\/KE). Each patient enrolled in the study has given their informed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}